Enhancement of murine phenytoin teratogenicity by the gamma‐glutamylcysteine synthetase inhibitor L‐buthionine‐(S, R)‐sulfoximine and by the glutathione depletor diethyl maleate

Teratology

Volumn 40, Issue 2, 1989, Pages 127-141

  Wong, Mayme ^a   Helston, Lori M J ^a   Wells, Peter G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; MALEIC ACID DIETHYL ESTER; PHENYTOIN;

ANIMAL EXPERIMENT; CLEFT PALATE; DRUG COMBINATION; DRUG TOXICITY; FEMALE; FETUS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOLOGY; PREGNANCY; PRIORITY JOURNAL; TERATOGENICITY;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMAL; BODY WEIGHT; BUTHIONINE SULFOXIMINE; CLEFT PALATE; FEMALE; FETAL RESORPTION; FETAL VIABILITY; GLUTATHIONE; INFUSIONS, PARENTERAL; MALEATES; METHIONINE SULFOXIMINE; MICE; PHENYTOIN; PREGNANCY; SUPPORT, NON-U.S. GOV'T; TERATOGENS;

EID: 0024458721     PISSN: 00403709     EISSN: 10969926     Source Type: Journal    
DOI: 10.1002/tera.1420400206     Document Type: Article

References (53)

1. Inhibition and enhancement of microsomal drug metabolism by diethyl maleate
2. Glutathione depletion in isolated hepatocytes: Its relation to lipid peroxidation and cell damage
3. Isolated cleft palate in A/J mice after transitory exposure to drinking water deprivation and low humidity in pregnancy
4. Near‐total glutathione depletion and age‐specific cataracts induced by buthionine sulfoximine in mice
5. A high‐performance liquid chromatograhic assay for reduced and oxidised glutathione in embryonic, neonatal and adult tissues using a porous grahite electrochemical detector
6. Effect of diethyl maleate and other glutathione depletors on protein synthesis
7. Transient depletion of lung glutathione by diethyl maleate enhances oxygen toxicity
8. Toxic effects of extended glutathione depletion by buthionine sulfoximine in murine mammary carcinoma cells
9. The effect of buthionine sulfoximine (BSO) on glutathione depletion and xenobiotic biotransformation
10. Glutathione depletion and resynthesis in laboratory animals
11. Variable patterns of malformation in the mouse fetal hydantion syndrome
12. Association of cleft lip and atrial septal defect in mice: A preliminary report
13. Depletion of glutathione by inhibition of biosynthesis
14. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S‐n, ‐butyl‐homocysteine sulfoximine)
15. Chemical‐biological reactions common to teratogenesis and mutagenesis
16. Effect of phenobarbital and SKF 525A pretreatment on diphenylhydantoin teratogenicity in mice
17. Proposed mechanism for diphenylhydantion‐induced teratogenesis
18. Differential glutathione depletion by L‐buthionine‐S, R,‐sulfoximine in rat embryo versus visceral yolk sac in vivo and in vitro
19. Regulation of intracellular glutathione in rat embryos and visceral yolk sacs and its effect on 2‐nitrosofluorene induced malformations in the whole embryoculture system
20. Effects of diethyl maleate on non‐protein sulfhydryl content and cellular functions of mouse thymocytes in vitro
21. Thyroxin‐induced differential mortality of mouse embryos with cleft lip
22. In vitro bioactivation of phenytion to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase and thyroid peroxidase
23. Glutathione in the developing mouse liver. I. Developmental curve and depletion after acetaminophen treatment
24. Pharmacological studies on the potentiation of phenytion teratogenicity by acetaminophen
25. Phenytion teratogenesis: Correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue
26. Possible regulation mechanism of microsomal glutathione S‐transferase activity in rat liver
27. Selective modification of glutathione metabolism
28. New developments in glutathione metabolism and their potential application in therapy
29. Acetaminophen‐induced hepatic necrosis. I. Protective role of glutathione
30. Studies on 5,5‐diphenylhydantoin irreversible binding to rat liver microsomal proteins
31. Chemical depletion of glutathione in vivo
32. Biosynthesis and regulation of glutathione: Toxicological implications
33. Effect of glutathione depletion by buthionine sulfoximine on rat embryonic development in vitro
34. Genetic predisposition to phenytoin‐induced birth defects
35. Relationship between ossification and body weight of the CD‐1 mouse fetus exposed in utero to anticonvulsant drugs
36. Mechanisms of phenytoin‐induced malformations in a mouse model
37. Effects of the long‐term depletion of reduced glutathione in mice administered L‐buthionine‐(S, R)‐sulfoximine
38. Differential lipid peroxidative response of rat liver and lung tissues to glutathione depletion induced in vivo by diethyl maleate: Effect of the antioxidant flavonoid (+)‐cyanidanol‐3
39. Toxicologic enhancement by a combination of drugs which deplete hepatic glutathione: Acetaminophen and doxorubicin (Adriamycin)
40. Significance of the phenytoin reactive arene oxide intermediate, its oxepin tautomer, and clinical factors modifying their roles in phenytoin‐induced teratology
41. Inhibition of trimethadione and dimethadione teratogenicity by cyclooxygenase inhibitor acetylsalicylic acid: A unifying hypothesis for the teratologic effects of hydantoin anticonvulsants and structurally related compounds
42. Effect of the tumor promoter 12‐0‐tetradecanolyphorbol‐13‐acetate (TPA) on phenytoin embryopathy
43. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid and alpha‐phenyl‐N‐t‐butylnitrone: Implications for bioactivation by prostaglandin synthetase
44. The effect of buthionine sulfoximine, an inhibitor of glutathione synthesis, on hepatic drug metabolism in the male mouse
45. Glutathione synthesis and degradation in fetal and adult rat liver and Novikoff hepatoma
46. Effect of glutathione modulation on phenytoin embryopathy
47. Effects of N‐acetylcysteine on fetal development and on phenytoin teratogenicity in mice
48. Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in vivo